✦ LIBER ✦

Psoralen–ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo

✍ Scribed by D Parsad; AJ Kanwar; B Kumar

Book ID: 111094376
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 71 KB
Volume: 20
Category: Article
ISSN: 0926-9959
DOI: 10.1111/j.1468-3083.2006.01413.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Narrow-band ultraviolet B phototherapy f

Narrow-band ultraviolet B phototherapy for the treatment of vitiligo: evidence against an autoimmune pathogenesis

✍ B Engin; I Baysal; I Reisli; M Özdemir; H Toy 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Cochrane Database of Systematic Reviews

Cochrane Database of Systematic Reviews (Reviews) || Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis

✍ Chen, Xiaomei 📂 Article 📅 2013 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 741 KB

Treatment of progressive macular hypomel

Treatment of progressive macular hypomelanosis with narrow-band ultraviolet B phototherapy

✍ Yung-Chien Kwah; Wei-Sheng Chong; Colin Thiam-Seng Theng; Boon-Kee Goh 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

Narrow-band ultraviolet B is a useful an

Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo

✍ Lubomira Scherschun; Jane J. Kim; Henry W. Lim 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Phototherapy with narrowband ultraviolet

Phototherapy with narrowband ultraviolet B light the treatment of vitiligo

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Narrow-band UV-B micro-phototherapy: a n

Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo

✍ G Menchini; E Tsoureli-Nikita; J Hercogova 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB

## ABSTRACT **Background** Vitiligo is a common, acquired, often familial, melanocytopenic disorder with focal depigmentation of the skin. There are several new treatments, that appear to have higher success rates than previous therapies for the treatment of vitiligo. Among these, the most promisin